Wed, Aug 5, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
A SQUARE

Fund in the offing - a niche segment within microfinance

Wednesday, October 24, 2007
Irrespective of gender - borrowers of microfinance demonstrate better credit worthiness..

A SQUARE :: 24Oct07 Fund in the offing - a niche segment within microfinance
Category Micro Finance
Author Sona Blessing
On a relative basis, however, women show higher credit worthiness owing to smaller size loans they take on and thanks to a specialised technology /group dynamic that comes into play.

While the repayment rates on loans given to both men and women are roughly the same - there is an interesting and marked difference in the way women actually allocate their earnings.
Download this research The many benefits of an A SQUARE subscription Recommend to a friend

<< A SQUARE archive sorted by date    << A SQUARE archive sorted by category

 Article link
More research related to Micro Finance

[15Apr08] [Micro Finance] A fund that has a "secured loan" structure in place
Heterogeneous loan profile - (remote/no correlation to financial markets)

Download

[20Jun07] [Micro Finance] Dexia Micro Credit Fund (BlueOrchard)
A commercial investment fund designed to refinance microfinance institutions specialised in financial services to small companies in emerging markets; targets returns of US 6 month LIBOR +/- 1-2%

Download

[20Mar07] [Micro Finance] Insights on global micro finance
More on microfinance

Download

[16Jan07] [Micro Finance] Responsability

Download

[16Jan07] [Micro Finance] Special Purpose Investing

Download
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

    From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

  2. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

    From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

  3. Performance - Some hedge fund small-cap energy stocks have been free falling, Dan Loeb's simple strategy destroys the market, Baupost lost 1.4% last quarter as energy bargains proved elusive[more]

    Some hedge fund small-cap energy stocks have been free falling From Marketrealist.com: According to a July 28, 2015, Bloomberg article, there was a 34% fall in small-cap energy stocks over the past three months. These shares are tracked by the Russell 2000 Energy Index. Small-cap energy

  4. Legal - Hedge funds hit Rothstein Kass with $75m malpractice suit, JPMorgan questioned on private bank’s hedge fund disclosures, Kijani fund, seized by regulators in Cayman Islands, spotlights risks in lightly regulated market[more]

    Hedge funds hit Rothstein Kass with $75m malpractice suit From Law360.com: Two investment funds have sued Rothstein Kass & Co. PC for at least $75 million, claiming the New Jersey auditing firm committed accounting malpractice by failing to properly scrutinize overblown valuations of the

  5. Assets - Hedge funds are getting smoked by the commodities slump, Global ETF assets could more than double by 2020[more]

    Hedge funds are getting smoked by the commodities slump From Businessinsider.in: The collapse in commodity prices has burnt another hedge fund. Vermillion, a commodity hedge fund backed by Carlyle Group, has seen its flagship fund's assets fall from nearly $2 billion to less $50 million,

banner